Details of the Target
General Information of Target
Target ID | LDTP12490 | |||||
---|---|---|---|---|---|---|
Target Name | Sphingosine kinase 2 (SPHK2) | |||||
Gene Name | SPHK2 | |||||
Gene ID | 56848 | |||||
Synonyms |
SK2; Sphingosine kinase 2; SK 2; SPK 2; EC 2.7.1.91 |
|||||
3D Structure | ||||||
Sequence |
MPKRAHWGALSVVLILLWGHPRVALACPHPCACYVPSEVHCTFRSLASVPAGIAKHVERI
NLGFNSIQALSETSFAGLTKLELLMIHGNEIPSIPDGALRDLSSLQVFKFSYNKLRVITG QTLQGLSNLMRLHIDHNKIEFIHPQAFNGLTSLRLLHLEGNLLHQLHPSTFSTFTFLDYF RLSTIRHLYLAENMVRTLPASMLRNMPLLENLYLQGNPWTCDCEMRWFLEWDAKSRGILK CKKDKAYEGGQLCAMCFSPKKLYKHEIHKLKDMTCLKPSIESPLRQNRSRSIEEEQEQEE DGGSQLILEKFQLPQWSISLNMTDEHGNMVNLVCDIKKPMDVYKIHLNQTDPPDIDINAT VALDFECPMTRENYEKLWKLIAYYSEVPVKLHRELMLSKDPRVSYQYRQDADEEALYYTG VRAQILAEPEWVMQPSIDIQLNRRQSTAKKVLLSYYTQYSQTISTKDTRQARGRSWVMIE PSGAVQRDQTVLEGGPCQLSCNVKASESPSIFWVLPDGSILKAPMDDPDSKFSILSSGWL RIKSMEPSDSGLYQCIAQVRDEMDRMVYRVLVQSPSTQPAEKDTVTIGKNPGESVTLPCN ALAIPEAHLSWILPNRRIINDLANTSHVYMLPNGTLSIPKVQVSDSGYYRCVAVNQQGAD HFTVGITVTKKGSGLPSKRGRRPGAKALSRVREDIVEDEGGSGMGDEENTSRRLLHPKDQ EVFLKTKDDAINGDKKAKKGRRKLKLWKHSEKEPETNVAEGRRVFESRRRINMANKQINP ERWADILAKVRGKNLPKGTEVPPLIKTTSPPSLSLEVTPPFPAISPPSASPVQTVTSAEE SSADVPLLGEEEHVLGTISSASMGLEHNHNGVILVEPEVTSTPLEEVVDDLSEKTEEITS TEGDLKGTAAPTLISEPYEPSPTLHTLDTVYEKPTHEETATEGWSAADVGSSPEPTSSEY EPPLDAVSLAESEPMQYFDPDLETKSQPDEDKMKEDTFAHLTPTPTIWVNDSSTSQLFED STIGEPGVPGQSHLQGLTDNIHLVKSSLSTQDTLLIKKGMKEMSQTLQGGNMLEGDPTHS RSSESEGQESKSITLPDSTLGIMSSMSPVKKPAETTVGTLLDKDTTTATTTPRQKVAPSS TMSTHPSRRRPNGRRRLRPNKFRHRHKQTPPTTFAPSETFSTQPTQAPDIKISSQVESSL VPTAWVDNTVNTPKQLEMEKNAEPTSKGTPRRKHGKRPNKHRYTPSTVSSRASGSKPSPS PENKHRNIVTPSSETILLPRTVSLKTEGPYDSLDYMTTTRKIYSSYPKVQETLPVTYKPT SDGKEIKDDVATNVDKHKSDILVTGESITNAIPTSRSLVSTMGEFKEESSPVGFPGTPTW NPSRTAQPGRLQTGIPVTTSGENLTDPPLLKELEDVDFTSEFLSSLTVSTPFHQEEAGSS TTLSSIKVEVASSQAETTTLDQDHLETTVAILLSETRPQNHTPTAARMKEPASSSPSTIL MSLGQTTTTKPALPSPRISQASRDSKENVFLNYVGNPETEATPVNNEGTQHMSGPNELST PSSDQDAFNLSTKLELEKQVFGSRSLPRGPDSQRQDGRVHASHQLTRVPAKPILPTATVR LPEMSTQSASRYFVTSQSPRHWTNKPEITTYPSGALPENKQFTTPRLSSTTIPLPLHMSK PSIPSKFTDRRTDQFNGYSKVFGNNNIPEARNPVGKPPSPRIPHYSNGRLPFFTNKTLSF PQLGVTRRPQIPTSPAPVMRERKVIPGSYNRIHSHSTFHLDFGPPAPPLLHTPQTTGSPS TNLQNIPMVSSTQSSISFITSSVQSSGSFHQSSSKFFAGGPPASKFWSLGEKPQILTKSP QTVSVTAETDTVFPCEATGKPKPFVTWTKVSTGALMTPNTRIQRFEVLKNGTLVIRKVQV QDRGQYMCTASNLHGLDRMVVLLSVTVQQPQILASHYQDVTVYLGDTIAMECLAKGTPAP QISWIFPDRRVWQTVSPVEGRITLHENRTLSIKEASFSDRGVYKCVASNAAGADSLAIRL HVAALPPVIHQEKLENISLPPGLSIHIHCTAKAAPLPSVRWVLGDGTQIRPSQFLHGNLF VFPNGTLYIRNLAPKDSGRYECVAANLVGSARRTVQLNVQRAAANARITGTSPRRTDVRY GGTLKLDCSASGDPWPRILWRLPSKRMIDALFSFDSRIKVFANGTLVVKSVTDKDAGDYL CVARNKVGDDYVVLKVDVVMKPAKIEHKEENDHKVFYGGDLKVDCVATGLPNPEISWSLP DGSLVNSFMQSDDSGGRTKRYVVFNNGTLYFNEVGMREEGDYTCFAENQVGKDEMRVRVK VVTAPATIRNKTYLAVQVPYGDVVTVACEAKGEPMPKVTWLSPTNKVIPTSSEKYQIYQD GTLLIQKAQRSDSGNYTCLVRNSAGEDRKTVWIHVNVQPPKINGNPNPITTVREIAAGGS RKLIDCKAEGIPTPRVLWAFPEGVVLPAPYYGNRITVHGNGSLDIRSLRKSDSVQLVCMA RNEGGEARLILQLTVLEPMEKPIFHDPISEKITAMAGHTISLNCSAAGTPTPSLVWVLPN GTDLQSGQQLQRFYHKADGMLHISGLSSVDAGAYRCVARNAAGHTERLVSLKVGLKPEAN KQYHNLVSIINGETLKLPCTPPGAGQGRFSWTLPNGMHLEGPQTLGRVSLLDNGTLTVRE ASVFDRGTYVCRMETEYGPSVTSIPVIVIAYPPRITSEPTPVIYTRPGNTVKLNCMAMGI PKADITWELPDKSHLKAGVQARLYGNRFLHPQGSLTIQHATQRDAGFYKCMAKNILGSDS KTTYIHVF |
|||||
Target Type |
Clinical trial
|
|||||
Target Bioclass |
Enzyme
|
|||||
Subcellular location |
Cytoplasm; Lysosome membrane
|
|||||
Function |
Catalyzes the phosphorylation of sphingosine to form sphingosine-1-phosphate (SPP), a lipid mediator with both intra- and extracellular functions. Also acts on D-erythro-dihydrosphingosine, D-erythro-sphingosine and L-threo-dihydrosphingosine. Binds phosphoinositides. In contrast to prosurvival SPHK1, has a positive effect on intracellular ceramide levels, inhibits cells growth and enhances apoptosis. In mitochondria, is important for cytochrome-c oxidase assembly and mitochondrial respiration. The SPP produced in mitochondria binds PHB2 and modulates the regulation via PHB2 of complex IV assembly and respiration. In nucleus, plays a role in epigenetic regulation of gene expression. Interacts with HDAC1 and HDAC2 and, through SPP production, inhibits their enzymatic activity, preventing the removal of acetyl groups from lysine residues with histones. Up-regulates acetylation of histone H3-K9, histone H4-K5 and histone H2B-K12. In nucleus, may have an inhibitory effect on DNA synthesis and cell cycle. In mast cells, is the main regulator of SPP production which mediates calcium influx, NF-kappa-B activation, cytokine production, such as TNF and IL6, and degranulation of mast cells. In dopaminergic neurons, is involved in promoting mitochondrial functions regulating ATP and ROS levels. Also involved in the regulation of glucose and lipid metabolism.
|
|||||
TTD ID | ||||||
Uniprot ID | ||||||
DrugMap ID | ||||||
Ensemble ID | ||||||
HGNC ID | ||||||
ChEMBL ID |
Probe(s) Labeling This Target
ABPP Probe
Probe name | Structure | Binding Site(Ratio) | Interaction ID | Ref | |
---|---|---|---|---|---|
DBIA Probe Info |
![]() |
C262(1.83) | LDD3314 | [1] | |
IA-alkyne Probe Info |
![]() |
C597(2.98) | LDD2184 | [2] | |
NAIA_4 Probe Info |
![]() |
N.A. | LDD2226 | [3] | |
IPM Probe Info |
![]() |
N.A. | LDD0005 | [4] |
PAL-AfBPP Probe
Probe name | Structure | Binding Site(Ratio) | Interaction ID | Ref | |
---|---|---|---|---|---|
C055 Probe Info |
![]() |
13.18 | LDD1752 | [5] | |
C056 Probe Info |
![]() |
26.35 | LDD1753 | [5] | |
C070 Probe Info |
![]() |
11.79 | LDD1766 | [5] | |
C072 Probe Info |
![]() |
25.81 | LDD1768 | [5] | |
C107 Probe Info |
![]() |
8.11 | LDD1794 | [5] | |
C134 Probe Info |
![]() |
28.84 | LDD1816 | [5] | |
C135 Probe Info |
![]() |
9.58 | LDD1817 | [5] | |
C140 Probe Info |
![]() |
14.62 | LDD1822 | [5] | |
C143 Probe Info |
![]() |
13.64 | LDD1825 | [5] | |
C169 Probe Info |
![]() |
36.00 | LDD1849 | [5] | |
C173 Probe Info |
![]() |
7.01 | LDD1853 | [5] | |
C174 Probe Info |
![]() |
4.92 | LDD1854 | [5] | |
C225 Probe Info |
![]() |
5.94 | LDD1898 | [5] | |
C228 Probe Info |
![]() |
20.82 | LDD1901 | [5] | |
C346 Probe Info |
![]() |
16.68 | LDD2007 | [5] | |
C367 Probe Info |
![]() |
5.66 | LDD2028 | [5] | |
C400 Probe Info |
![]() |
6.87 | LDD2059 | [5] |
Competitor(s) Related to This Target
Competitor ID | Name | Cell line | Binding Site(Ratio) | Interaction ID | Ref |
---|---|---|---|---|---|
LDCM0575 | Fragment13 | Ramos | C597(1.34) | LDD2192 | [2] |
LDCM0576 | Fragment14 | Ramos | C597(1.92) | LDD2193 | [2] |
LDCM0580 | Fragment21 | Ramos | C597(1.33) | LDD2195 | [2] |
LDCM0582 | Fragment23 | Ramos | C597(1.48) | LDD2196 | [2] |
LDCM0578 | Fragment27 | Ramos | C597(1.05) | LDD2197 | [2] |
LDCM0586 | Fragment28 | Ramos | C597(0.85) | LDD2198 | [2] |
LDCM0588 | Fragment30 | Ramos | C597(1.02) | LDD2199 | [2] |
LDCM0589 | Fragment31 | Ramos | C597(1.04) | LDD2200 | [2] |
LDCM0468 | Fragment33 | Ramos | C597(1.13) | LDD2202 | [2] |
LDCM0596 | Fragment38 | Ramos | C597(1.04) | LDD2203 | [2] |
LDCM0566 | Fragment4 | Ramos | C597(2.98) | LDD2184 | [2] |
LDCM0610 | Fragment52 | Ramos | C597(1.08) | LDD2204 | [2] |
LDCM0614 | Fragment56 | Ramos | C597(0.87) | LDD2205 | [2] |
LDCM0022 | KB02 | 42-MG-BA | C262(2.25) | LDD2244 | [1] |
LDCM0023 | KB03 | 42-MG-BA | C262(3.08) | LDD2661 | [1] |
LDCM0024 | KB05 | IGR37 | C262(1.83) | LDD3314 | [1] |
LDCM0627 | NUDT7-COV-1 | HEK-293T | C597(6.54) | LDD2206 | [6] |
The Interaction Atlas With This Target
The Protein(s) Related To This Target
Transporter and channel
Protein name | Family | Uniprot ID | |||
---|---|---|---|---|---|
Optineurin (OPTN) | . | Q96CV9 |
The Drug(s) Related To This Target
Phase 3
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Abc294640 | Small molecular drug | D0X6BX |
Investigative
References